AU7161096A - Compositions and methods for inhibiting the binding of pecam - Google Patents

Compositions and methods for inhibiting the binding of pecam

Info

Publication number
AU7161096A
AU7161096A AU71610/96A AU7161096A AU7161096A AU 7161096 A AU7161096 A AU 7161096A AU 71610/96 A AU71610/96 A AU 71610/96A AU 7161096 A AU7161096 A AU 7161096A AU 7161096 A AU7161096 A AU 7161096A
Authority
AU
Australia
Prior art keywords
pecam
inhibiting
binding
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71610/96A
Inventor
Pamela Beck
Robert J. Bjercke
Phi Nga Kint
Kaijun Ren
B. Mitch Revelle
Sid Sherwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encysive Pharmaceuticals Inc
Original Assignee
Texas Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas Biotechnology Corp filed Critical Texas Biotechnology Corp
Publication of AU7161096A publication Critical patent/AU7161096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU71610/96A 1995-09-19 1996-09-18 Compositions and methods for inhibiting the binding of pecam Abandoned AU7161096A (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US003968 1993-01-21
US394195P 1995-09-19 1995-09-19
US398595P 1995-09-19 1995-09-19
US396895P 1995-09-19 1995-09-19
US395395P 1995-09-19 1995-09-19
US395195P 1995-09-19 1995-09-19
US399695P 1995-09-19 1995-09-19
US003996 1995-09-19
US003953 1995-09-19
US003941 1995-09-19
US003985 1995-09-19
US003951 1995-09-19
PCT/US1996/014940 WO1997010839A1 (en) 1995-09-19 1996-09-18 Compositions and methods for inhibiting the binding of pecam

Publications (1)

Publication Number Publication Date
AU7161096A true AU7161096A (en) 1997-04-09

Family

ID=27555470

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71610/96A Abandoned AU7161096A (en) 1995-09-19 1996-09-18 Compositions and methods for inhibiting the binding of pecam

Country Status (2)

Country Link
AU (1) AU7161096A (en)
WO (1) WO1997010839A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955443A (en) * 1998-03-19 1999-09-21 Isis Pharmaceuticals Inc. Antisense modulation of PECAM-1
US7566765B2 (en) 2000-03-06 2009-07-28 Rigel Pharmaceuticals, Inc. Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
JP4845102B2 (en) * 2006-03-24 2011-12-28 雪印メグミルク株式会社 peptide
US10584157B2 (en) * 2015-03-16 2020-03-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Isolated peptides derived from the B7 ligand dimer interface and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264554A (en) * 1990-01-19 1993-11-23 The Blood Center Of Southeastern Wisconsin, Inc. Platelet cell adhesion molecule and variants thereof
EP0563329B1 (en) * 1990-12-21 1998-03-18 Curative Technologies, Inc. Angiogenic peptides
US5510332A (en) * 1994-07-07 1996-04-23 Texas Biotechnology Corporation Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor

Also Published As

Publication number Publication date
WO1997010839A1 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
AU1831597A (en) Methods and compositions for inhibiting hexokinase
AU5922096A (en) Methods and compositions for inhibiting 5alpha-reductase act ivity
AU5439996A (en) Compositions and methods for treating pain
AU5668796A (en) Dermatological-wound healing compositions and methods for pr eparing and using same
AU4863196A (en) Appetite suppression factor and related methods
AU2757097A (en) Method of coating and compositions for use therein
AU7212996A (en) Compositions and methods for controlling harmful fungi
AU2113295A (en) Novel compositions and methods for water treatment
AU9214398A (en) Compositions and methods for treating water
AU6856496A (en) Compositions and methods for inhibiting corrosion
AU6489396A (en) Methods of making viscoelastic compositions
AU1751795A (en) Liposome compositions and methods for the treatment of atherosclerosis
AU6485996A (en) Methods and compositions for modulation and inhibition of teomerase
EP0831920A4 (en) Novel cathepsin and methods and compositions for inhibition thereof
AU2243797A (en) Methods and compositions for inhibiting hexokinase
AU671577B3 (en) Compositions and methods for the control of smoking
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU6986696A (en) Compositions and methods for controlling harmful fungi
AU3768095A (en) Herbicidal composition and method
AU6150498A (en) Methods and compositions for the inhibition of interleukin-12 production
AU2670897A (en) Fibulin pharmaceutical compositions and related methods
AU2821295A (en) Compositions and methods for the treatment of tumors
AU5631096A (en) Antihistamine-wound healing compositions and methods for pre paring and using same
AUPN137895A0 (en) Composition and method
AU6274694A (en) Methods and compositions for the inhibition of complement activation